Key result
TTVR linked to fatal prosthetic valve endocarditis at 6 months in a recent case report.
Why the study?
Fatal prosthetic valve endocarditis following orthotopic TTVR appears exceptionally rare, with detailed pathologic description through specialist cardiovascular autopsy remaining limited.
Case Report (n=1)
Fatal prosthetic valve endocarditis after TTVR can present with nonspecific symptoms and rapid deterioration, highlighting the need for specialist cardiovascular pathology in unexplained deaths following transcatheter valve interventions.
Alerts to atypical fatal PVE after TTVR; single case leaves open incidence and surveillance needs.
BACKGROUND: Transcatheter tricuspid valve replacement (TTVR) is an emerging therapy for severe tricuspid regurgitation with an evolving complication profile. Fatal prosthetic valve endocarditis (PVE) following orthotopic TTVR appears exceptionally rare, with detailed pathologic description through specialist cardiovascular autopsy remaining limited. CASE SUMMARY: A 65-year-old man with severe functional tricuspid regurgitation and persistent atrial fibrillation underwent TTVR. The following day, he developed complete heart block requiring pacemaker implantation. He remained well at 1 and 3 months, with improving symptoms and unremarkable bloods. At 6 months, he developed nonspecific viral-like symptoms over 48 hours culminating in death at home. Routine postmortem examination attributed death to coronary artery disease. Specialist cardiovascular pathology demonstrated PVE with large vegetations, atrioventricular nodal obliteration, left atrial communication enabling systemic septic embolization, diffuse coronary microembolization, and widespread left ventricular microabscesses. DISCUSSION: Fatal PVE after TTVR may present with nonspecific prodromal symptoms. Unexplained death after transcatheter valve intervention warrants specialist cardiovascular pathology. TAKE HOME MESSAGE: Prosthetic valve endocarditis after transcatheter tricuspid valve replacement may present with nonspecific symptoms and rapid clinical deterioration; unexplained death should prompt specialist cardiovascular pathology.
No takes yet. Share an insight, caveat, or question.
Panday et al. (2026) conducted a case report in Severe functional tricuspid regurgitation and persistent atrial fibrillation (n=1). Transcatheter tricuspid valve replacement (TTVR) was evaluated on Fatal prosthetic valve endocarditis. Transcatheter tricuspid valve replacement was followed by fatal prosthetic valve endocarditis at 6 months in a 65-year-old man, presenting with nonspecific symptoms and rapid deterioration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: